A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone
This study found that nafarelin 200 micrograms daily improved endometriosis symptoms similarly to 400 micrograms daily, and adding norethisterone further reduced hot flushes and improved bleeding control.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- A comparison of nafarelin acetate and danazol in the treatment of endometriosis via openalex
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone via openalex
- Can hormone replacement therapy be used during medical therapy of endometriosis? via openalex
- Correction to: "Friedman AJ, Hornstein MD: Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain. Fertil Steril 1993;60:236-41" via openalex
- Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain via openalex
- Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy via openalex
- Hormonal therapies for endometriosis: implications for bone metabolism. via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Pharmacologic management of endometriosis. via openalex
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
- The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
- The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
- Treatment of Endometriosis with the Luteinizing Hormone-Releasing Hormone Agonist Nafarelin. Effect on Bone Turnover and Bone Mass via openalex
- W133578770 via openalex
- W2477008945 via openalex
- W2337521034 via openalex
- W2075860102 via openalex
- W2114962190 via openalex
- W2129449855 via openalex
- W2077563872 via openalex
- W1512318310 via openalex
- W2407038112 via openalex
Cited by (13)
- ABORDAGENS CONTEMPORÂNEAS PARA A GESTÃO DA ENDOMETRIOSE 2024
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not? 2023
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy 2017
- Endometriosis: A review of the diagnosis and pain management 2015
- Triptorelin for the treatment of endometriosis 2014
- Руководство европейского общества репродукции человека и эмбриологии (ESHRE): менеджмент женщин с эндометриозом 2014
- Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? 2010
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Endometriosis 2003
- Current Drug Therapy Recommendations for the Treatment of Endometriosis 1999
- The evidence for the management of endometriosis 1998
Source provenance
- europepmc
- last seen: 2026-06-18T06:15:08.409253+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:52.568893+00:00